text: Blockade of NMDA receptors by << memantine >> could theoretically confer disease-modifying activity in AD by inhibiting the "weak" [[ NMDA receptor ]]-dependent excitotoxicity that has been hypothesized to play a role in the progressive neuronal loss that underlies the evolving dementia.